BRIDGEWAY CAPITAL MANAGEMENT, LLC
Position in PLX — Protalix BioTherapeutics, Inc.
CIK 1107261
HOUSTON, TX
Position in PLX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$440,603
+$30,256 QoQ
Shares Held
189,100
0.0% QoQ
Ownership
0.235%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#15
of 101 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $87,985,615 across 108 Biotechnology names. PLX ranks #44 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GLUE |
Monte Rosa Therapeutics, Inc.
|
552,566 | $13,372,097 | |
| 2 | INVA |
Innoviva, Inc.
|
350,253 | $7,954,245 | |
| 3 | PBYI |
Puma Biotechnology, Inc.
|
791,616 | $6,420,005 | |
| 4 | RIGL |
Rigel Pharmaceuticals Inc
|
124,184 | $4,858,078 | |
| 5 | EXEL |
Exelixis, Inc.
|
66,100 | $3,596,501 | |
| 6 | CRMD |
CorMedix Inc.
|
434,132 | $3,407,936 | |
| 7 | KROS |
Keros Therapeutics, Inc.
|
265,017 | $2,835,681 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
22,000 | $1,794,540 |
All Filings in PLX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $440,603 | 189,100 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $410,347 | 189,100 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $340,380 | 189,100 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $419,802 | 189,100 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $279,868 | 189,100 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $484,096 | 189,100 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $341,032 | 181,400 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $187,465 | 183,790 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $215,034 | 183,790 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $231,575 | 183,790 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $371,646 | 208,790 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $263,591 | 158,790 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $317,580 | 158,790 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $280,959 | 133,790 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $183,292 | 133,790 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $139,141 | 133,790 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $173,081 | 158,790 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $30,517 | 28,790 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $78,323 | 58,890 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $752,329 | 393,890 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,349,555 | 302,591 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $771,705 | 212,591 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $822,727 | 212,591 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $660,562 | 174,291 | Shares | Sole | 2020-08-31 | |
| 2020-03-31 | $210,306 | 89,492 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||